What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Myocardial infarction
- Surgery
Gregg W. Stone mainly focuses on Internal medicine, Cardiology, Percutaneous coronary intervention, Myocardial infarction and Surgery.
Angioplasty, Stent, Revascularization, Coronary artery disease and Randomized controlled trial are the core of his Internal medicine study.
His Cardiology research is multidisciplinary, incorporating perspectives in Platelet aggregation inhibitor, Prospective cohort study and Hazard ratio.
His biological study spans a wide range of topics, including Clopidogrel, Framingham Risk Score and Conventional PCI.
The various areas that Gregg W. Stone examines in his Myocardial infarction study include Thrombosis and Clinical endpoint.
His Surgery study also includes fields such as
- Clinical trial that connect with fields like Intensive care medicine,
- Nephropathy that intertwine with fields like Renal function.
His most cited work include:
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up (1132 citations)
- Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study (645 citations)
- Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: An intravascular ultrasound study (584 citations)
What are the main themes of his work throughout his whole career to date?
Gregg W. Stone mostly deals with Internal medicine, Cardiology, Percutaneous coronary intervention, Myocardial infarction and Conventional PCI.
His study brings together the fields of Surgery and Internal medicine.
His Coronary artery disease, Angioplasty, Acute coronary syndrome, Artery and Intravascular ultrasound investigations are all subjects of Cardiology research.
His work deals with themes such as Stroke, Clopidogrel and Hazard ratio, which intersect with Percutaneous coronary intervention.
His study connects Clinical endpoint and Myocardial infarction.
His research integrates issues of Meta-analysis, Pooled analysis and Clinical trial in his study of Randomized controlled trial.
He most often published in these fields:
- Internal medicine (71.08%)
- Cardiology (65.04%)
- Percutaneous coronary intervention (38.08%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (71.08%)
- Cardiology (65.04%)
- Conventional PCI (30.99%)
In recent papers he was focusing on the following fields of study:
Gregg W. Stone spends much of his time researching Internal medicine, Cardiology, Conventional PCI, Percutaneous coronary intervention and Myocardial infarction.
His work on Revascularization, Randomized controlled trial, Artery and Stroke as part of general Internal medicine study is frequently connected to In patient, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His work carried out in the field of Randomized controlled trial brings together such families of science as Meta-analysis, Pooled analysis and Long term outcomes.
Gregg W. Stone interconnects Infarct size and Adverse effect in the investigation of issues within Conventional PCI.
His studies in Percutaneous coronary intervention integrate themes in fields like Coronary artery disease, Stent, Coronary artery bypass surgery and Hazard ratio.
Gregg W. Stone has researched Myocardial infarction in several fields, including Clinical endpoint and Clinical trial.
Between 2017 and 2021, his most popular works were:
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up (1132 citations)
- Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data (223 citations)
- Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document (140 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Myocardial infarction
- Surgery
Gregg W. Stone mainly investigates Percutaneous coronary intervention, Internal medicine, Cardiology, Myocardial infarction and Conventional PCI.
His study in Percutaneous coronary intervention is interdisciplinary in nature, drawing from both Coronary artery disease, Stent, Randomized controlled trial, Coronary artery bypass surgery and Revascularization.
In his work, Emergency medicine is strongly intertwined with Clinical trial, which is a subfield of Coronary artery disease.
In general Cardiology study, his work on Heart failure, Fractional flow reserve and Stenosis often relates to the realm of In patient, thereby connecting several areas of interest.
His research in Myocardial infarction intersects with topics in Clinical endpoint and Surgery.
Gregg W. Stone has included themes like Ostium, Adverse effect, Ejection fraction and Platelet aggregation inhibitor in his Conventional PCI study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
